China Health Management Corp.
CNHC
$0.005
-$0.0005-9.09%
| Weiss Ratings | CNHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | CNHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | CNHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.81 | |||
| Price History | CNHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -33.33% | |||
| 30-Day Total Return | -13.79% | |||
| 60-Day Total Return | -28.57% | |||
| 90-Day Total Return | 6.38% | |||
| Year to Date Total Return | 6.38% | |||
| 1-Year Total Return | -35.06% | |||
| 2-Year Total Return | -65.75% | |||
| 3-Year Total Return | -61.83% | |||
| 5-Year Total Return | -75.00% | |||
| 52-Week High % Change | -62.69% | |||
| 52-Week Low % Change | 212.50% | |||
| Price | CNHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.01 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Jun 27, 2023 | |||
| 52-Week High Price (Date) | Jan 17, 2024 | |||
| Valuation | CNHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 405.73K | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -1,357.06 | |||
| Earnings Per Share Growth | 719.28% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CNHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 21.10K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CNHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 214-691-0055 | |||
| Address | 8115 Preston Road Dallas, TX 75225 | |||
| Website | www.chinahealthcorp.com | |||
| Country | United States | |||
| Year Founded | 1996 | |||
| Profitability | CNHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -4,492.46% | |||
| Profit Margin | -4,495.85% | |||
| Management Effectiveness | CNHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -119.18% | |||
| Return on Equity | -- | |||
| Income Statement | CNHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 482.00K | |||
| Total Revenue (TTM) | 482.00K | |||
| Revenue Per Share | $22.84 | |||
| Gross Profit (TTM) | -9.73M | |||
| EBITDA (TTM) | -21.01M | |||
| EBIT (TTM) | -21.65M | |||
| Net Income (TTM) | -21.67M | |||
| Net Income Avl. to Common (TTM) | -21.67M | |||
| Total Revenue Growth (Q YOY) | -0.92% | |||
| Earnings Growth (Q YOY) | 46.60% | |||
| EPS Diluted (TTM) | -1.36K | |||
| EPS Diluted Growth (Q YOY) | 48.73% | |||
| Balance Sheet | CNHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | -- | |||
| Cash Per Share (Q) | -- | |||
| Total Current Assets (Q) | 6.21M | |||
| Total Preferred Equity (Q) | 13.79 | |||
| Total Equity (Q) | -938.70K | |||
| Current Ratio (Q) | 0.729 | |||
| Book Value Per Share (Q) | -$648.31 | |||
| Total Assets (Q) | 7.57M | |||
| Total Current Liabilities (Q) | 8.51M | |||
| Total Debt (Q) | 532.10K | |||
| Total Liabilities (Q) | 8.51M | |||
| Total Common Equity (Q) | -14.73M | |||
| Cash Flow | CNHC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -528.00K | |||
| Cash from Financing (TTM) | 6.34M | |||
| Net Change in Cash (TTM) | -487.20K | |||
| Levered Free Cash Flow (TTM) | 740.40K | |||
| Cash from Operations (TTM) | -6.30M | |||
